Genelux Alternatives & Competitors
12 companies similar to Genelux
Companies similar to Genelux
Seneca Therapeutics, Inc.
Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for...
Memgen, Inc.
Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
BioVaxys Technology Corp.
Antiviral and Anticancer Vaccine Platforms Harnessing the Power of T-Cells
Rival Readout
Competing with Genelux? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Precision Biologics, Inc.
Precision Biologics, Inc. has a cancer immunotherapy platform with 2 unique clinical stage...
CG Oncology
Attacking Bladder Cancer for a Better Tomorrow
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through ad...
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
MonTa Biosciences
Cancer Immunotherapy of Tomorrow
About Genelux
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, and Health Care industries, focusing on oncolytic immunotherapy to improve patient outcomes in cases of challenging solid...
Development of oncolytic immunotherapy, Clinical trial management, Expanded access programs
Cancer patients, Healthcare professionals, Clinical researchers
Oncolytic Immunotherapy, Solid Tumors, Cancer Treatment, Clinical-stage Biotech, Viral Therapy, Immunotherapies, Clinical Trials, Cancer Research, Cancer Therapy, Personalized Medicine
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Genelux: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Genelux on 2 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 7 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.